Prevalence and progression of mitochondrial diseases:: A study of 50 patients

被引:35
作者
Arpa, J
Cruz-Martínez, A
Campos, Y
Gutiérrez-Molina, M
García-Rio, F
Pérez-Conde, C
Martín, MA
Rubio, JC
Del Hoyo, P
Arpa-Fernández, A
Arenas, J
机构
[1] Hosp La Paz, Dept Neurol, Madrid 28046, Spain
[2] Hosp La Paz, Dept Neurophysiol, Madrid 28046, Spain
[3] Hosp 12 Octubre, Res Ctr, E-28041 Madrid, Spain
[4] Hosp La Paz, Dept Neuropathol, Madrid 28046, Spain
[5] Hosp La Paz, Dept Pneumol, Madrid 28046, Spain
[6] Severo Ochoa Hosp, Dept Clin Biochem, Leganes, Madrid, Spain
关键词
electromyography; genetics; mitochondrial disease; nerve conduction; prevalence; survival;
D O I
10.1002/mus.10507
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We report 50 patients with various clinical phenotypes of mitochondrial disease studied over the past 10 years in a large urban area (Madrid Health Area 5). The clinical phenotypes showed a large variety of abnormalities in molecular biology and biochemistry. The prevalence of mitochondrial diseases was found to be 5.7 per 100,000 in the population over 14 years of age. Clinical and electrophysiological assessment reveal signs of neuropathy in 10 patients. Electromyographic findings consistent with myopathy were obtained in 37 cases. Six patients died of medical complications. Disease phenotype influenced survival to some degree (P < 0.01). Age of onset and gender were not associated with differences in survival. Mitochondrial disease is thus far more common than expected and a common cause of chronic morbidity.
引用
收藏
页码:690 / 695
页数:6
相关论文
共 44 条
  • [1] Missense mutation in the mtDNA cytochrome b gene in a patient with myopathy
    Andreu, AL
    Bruno, C
    Shanske, S
    Shtilbans, A
    Hirano, M
    Krishna, S
    Hayward, L
    Systrom, DS
    Brown, RH
    DiMauro, S
    [J]. NEUROLOGY, 1998, 51 (05) : 1444 - 1447
  • [2] Andreu AL, 1999, ANN NEUROL, V45, P127, DOI 10.1002/1531-8249(199901)45:1<127::AID-ART20>3.0.CO
  • [3] 2-Y
  • [4] Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA
    Andreu, AL
    Hanna, MG
    Reichmann, H
    Bruno, C
    Penn, AS
    Tanji, K
    Pallotti, F
    Iwata, S
    Bonilla, E
    Lach, B
    Morgan-Hughes, J
    DiMauro, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (14) : 1037 - 1044
  • [5] Arpa J, 1997, ACTA NEUROL SCAND, V96, P65
  • [6] ARPE J, 1994, ACTA NEUROL SCAND, V90, P281
  • [7] EKBOMS SYNDROME - LIPOMAS, ATAXIA, AND NEUROPATHY WITH MERRF
    CALABRESI, PA
    SILVESTRI, G
    DIMAURO, S
    GRIGGS, RC
    [J]. MUSCLE & NERVE, 1994, 17 (08) : 943 - 945
  • [8] Clinical heterogeneity associated with mitochondrial DNA depletion in muscle
    Campos, Y
    Martín, MA
    García-Silva, T
    del Hoyo, P
    Rubio, JC
    Castro-Gago, M
    García-Peñas, J
    Casas, J
    Cabello, A
    Ricoy, JR
    Arenas, J
    [J]. NEUROMUSCULAR DISORDERS, 1998, 8 (08) : 568 - 573
  • [9] Mitochondrial encephalomyopathies
    Castro-Gago, M
    Novo-Rodríguez, MI
    Pintos-Martíez, E
    Campos, Y
    Arenas, J
    Eirís-Puñal, J
    [J]. REVISTA DE NEUROLOGIA, 2000, 31 (03) : 263 - 282
  • [10] Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.3.CO